Bonviva – a new bisphosphonate for the treatment of postmenopausal osteoporosis, an inhibitor of bone resorption and osteoclast activity. In women at menopause reduces the increased rate of bone renewal to the level of reproductive age, resulting in a general progressive increase in bone mass. Used for treatment and prevention of postmenopausal osteoporosis in women, prevention of fractures.
$120.00 – $550.00
Compare29110 Inkster Rd. Suite #250, Southfield, MI 48034, USA
We use encrypted SSL security to ensure your card information is 100% protected